Marketed by Novocure, the Optune device consists of four inter-connected patches that cover the skull and deliver the company’s patented Tumour Treating Fields (TTFields). These electrical ...
Investor's Business Daily on MSN4mon
Novocure Withdraws Massive Gain On FDA Approval. Why It Could Struggle To Gain Traction.On Tuesday the company announced the FDA approved its Optune Lua device for non-small cell lung cancer treatment. Optune Lua ...
Novocure has launched Optune, its first TTFields delivery system, for the treatment of glioblastoma multiforme and potentially other solid tumor indications. For over 100 years, surgery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback